Commercial Organ Chip Platforms & Consumables
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring commercial organ chip platforms and consumables, including microfluidic chips and proprietary supplies for evaluating standardized, industry-relevant platforms aligned with CBER's advanced in vitro models. The solicitation is estimated to release on May 1, 2027, with award anticipated September 1, 2027.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Center for Biologics Evaluation and Research acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
Required for purchasing commercial microfluidic chips and proprietary supplies. Critical for evaluating standardized, industry-relevant platforms aligned with CBER's focus on advanced in vitro models.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast